Published July 2008 | Version v1
Journal article

Clinical study on 131I therapy graves disease complicated with peripheral blood leukcytopenia

  • 1. Department of Nuclear Medicine, the Third People's Hospital of Chingqing, Chongqing (China)
  • 2. Department of Internal Medicine, the Third People's Hospital of Chongqing, Chongqing (China)

Description

Objective: To investigate the effect of 131I therapy Graves disease (GD) complicated with peripheral blood leukopenia in hyperthyroid patients. Methods: Serum T3, T4, TSH levels and peripheral blood white blood cell counts were determined in 16 GD complicated with leukopenia patients both before and after 131I therapy. Results: 131I treatment of GD complicated with leukopenia patients was very successful (P<0.01), the cured rate was 100%. The peripheral blood white blood cell counts were few changes in GD patients both before and after 131I T3, T4, TSH levels was decreased within three months after 131I therapy. Conclusion: The application of 131I to treat GD complicated with leukopenia was very successful. The therapeutic dose of 131I was no remarkable effect on peripheral blood white blood cell. (authors)

Additional details

Publishing Information

Journal Title
International Journal of Radiation Medicine and Nuclear Medicine
Journal Volume
32
Journal Issue
4
Journal Page Range
p. 229-231
ISSN
1673-4114

Optional Information

Notes
2 tabs., 6 refs.